메뉴 건너뛰기




Volumn 15, Issue 1, 2017, Pages

Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans

(128)  Kimura, Yukiko a   Grevich, Sriharsha b   Beukelman, Timothy c   Morgan, Esi d   Nigrovic, Peter A e   Mieszkalski, Kelly f   Graham, T Brent g   Ibarra, Maria h   Ilowite, Norman i   Klein Gitelman, Marisa j   Onel, Karen k   Prahalad, Sampath l   Punaro, Marilynn m   Ringold, Sarah b   Toib, Dana n   Van Mater, Heather o   Weiss, Jennifer E a   Weiss, Pamela F p   Schanberg, Laura E o   Abramson, L q   more..


Author keywords

Biologic response modifiers; Comparative effectiveness; Pediatric rheumatology; Registries; Still's disease; Systemic Juvenile Idiopathic Arthritis

Indexed keywords

ANAKINRA; CANAKINUMAB; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; METHOTREXATE; PREDNISONE; TOCILIZUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

EID: 85018462181     PISSN: None     EISSN: 15460096     Source Type: Journal    
DOI: 10.1186/s12969-017-0157-1     Document Type: Article
Times cited : (38)

References (27)
  • 1
    • 79959370461 scopus 로고    scopus 로고
    • Juvenile idiopathic arthritis
    • Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138-49.
    • (2011) Lancet , vol.377 , Issue.9783 , pp. 2138-2149
    • Prakken, B.1    Albani, S.2    Martini, A.3
  • 2
    • 79953323633 scopus 로고    scopus 로고
    • A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
    • Quartier P, Allantz F, Cimaz R, Pillet P, Msesiaen C, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011;70(5):747-54.
    • (2011) Ann Rheum Dis , vol.70 , Issue.5 , pp. 747-754
    • Quartier, P.1    Allantz, F.2    Cimaz, R.3    Pillet, P.4    Msesiaen, C.5
  • 5
    • 40749152243 scopus 로고    scopus 로고
    • Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
    • Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371(9617):998-1006.
    • (2008) Lancet , vol.371 , Issue.9617 , pp. 998-1006
    • Yokota, S.1    Imagawa, T.2    Mori, M.3    Miyamae, T.4    Aihara, Y.5    Takei, S.6    Iwata, N.7    Umebayashi, H.8    Murata, T.9    Miyoshi, M.10
  • 6
    • 84885103190 scopus 로고    scopus 로고
    • 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications
    • Ringold S, Weiss PF, Beukelman T, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, Nigrovic PA, Robinson AB, et al. 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013;65(10):2499-512.
    • (2013) Arthritis Rheum , vol.65 , Issue.10 , pp. 2499-2512
    • Ringold, S.1    Weiss, P.F.2    Beukelman, T.3    DeWitt, E.M.4    Ilowite, N.T.5    Kimura, Y.6    Laxer, R.M.7    Lovell, D.J.8    Nigrovic, P.A.9    Robinson, A.B.10
  • 7
    • 79957483535 scopus 로고    scopus 로고
    • 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
    • Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, Ilowite NT, Kimura Y, Laxer RM, Lovell DJ, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465-82.
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , Issue.4 , pp. 465-482
    • Beukelman, T.1    Patkar, N.M.2    Saag, K.G.3    Tolleson-Rinehart, S.4    Cron, R.Q.5    DeWitt, E.M.6    Ilowite, N.T.7    Kimura, Y.8    Laxer, R.M.9    Lovell, D.J.10
  • 8
    • 84997848582 scopus 로고    scopus 로고
    • Outcome and trends in treatment of systemic juvenile idiopathic arthritis in the German National Pediatric Rheumatological Database from 2000 to 2013
    • Klotsche J, Raab A, Niewerth M, Sengler C, Ganser G, Kallinich T, Niehues T, Hufnagel M, Thon A, Hospach T, et al. Outcome and trends in treatment of systemic juvenile idiopathic arthritis in the German National Pediatric Rheumatological Database from 2000 to 2013. Arthritis Rheum. 2016;68(12):3023-34.
    • (2016) Arthritis Rheum , vol.68 , Issue.12 , pp. 3023-3034
    • Klotsche, J.1    Raab, A.2    Niewerth, M.3    Sengler, C.4    Ganser, G.5    Kallinich, T.6    Niehues, T.7    Hufnagel, M.8    Thon, A.9    Hospach, T.10
  • 10
    • 79551654446 scopus 로고    scopus 로고
    • Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series
    • Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63(2):545-55.
    • (2011) Arthritis Rheum , vol.63 , Issue.2 , pp. 545-555
    • Nigrovic, P.A.1    Mannion, M.2    Prince, F.H.3    Zeft, A.4    Rabinovich, C.E.5
  • 11
    • 84898640609 scopus 로고    scopus 로고
    • Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study
    • Vastert SJ, de Jager W, Noordman BJ, Holzinger D, Kuis W, Prakken BJ, Wulffraat NM. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheum. 2014;66(4):1034-43.
    • (2014) Arthritis Rheum , vol.66 , Issue.4 , pp. 1034-1043
    • Vastert, S.J.1    Jager, W.2    Noordman, B.J.3    Holzinger, D.4    Kuis, W.5    Prakken, B.J.6    Wulffraat, N.M.7
  • 12
    • 33646477692 scopus 로고    scopus 로고
    • Predictors of disease course and remission in systemic Juvenile Idiopathic Arthritis
    • Singh-Grewal D, Schenider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic Juvenile Idiopathic Arthritis. Arthritis Rheum. 2006;54(5):1595-601.
    • (2006) Arthritis Rheum , vol.54 , Issue.5 , pp. 1595-1601
    • Singh-Grewal, D.1    Schenider, R.2    Bayer, N.3    Feldman, B.M.4
  • 13
    • 0033763981 scopus 로고    scopus 로고
    • Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study
    • Spiegel LR, Schneider R, Lang BA, Silverman ED, Laxer RM, Stephens D. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum. 2000;43:2402-9.
    • (2000) Arthritis Rheum , vol.43 , pp. 2402-2409
    • Spiegel, L.R.1    Schneider, R.2    Lang, B.A.3    Silverman, E.D.4    Laxer, R.M.5    Stephens, D.6
  • 15
    • 68249103874 scopus 로고    scopus 로고
    • Comparative effectiveness research: a report from the Institute of Medicine
    • Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009;151(3):203-5.
    • (2009) Ann Intern Med , vol.151 , Issue.3 , pp. 203-205
    • Sox, H.C.1    Greenfield, S.2
  • 16
    • 84954304921 scopus 로고    scopus 로고
    • Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan
    • Yokota S, Itoh Y, Morio T, Origasa H, Sumitomo N, Tomobe M, Tanaka K, Minota S. Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan. Ann Rheum Dis. 2016;75(9):1654-60.
    • (2016) Ann Rheum Dis , vol.75 , Issue.9 , pp. 1654-1660
    • Yokota, S.1    Itoh, Y.2    Morio, T.3    Origasa, H.4    Sumitomo, N.5    Tomobe, M.6    Tanaka, K.7    Minota, S.8
  • 18
    • 84906657232 scopus 로고    scopus 로고
    • Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: comment on the article by DeWitt et al
    • Kimura Y, DeWitt EM, Beukelman T, Stoll ML, Nigrovic PA, Onel K, Prahalad S, Angeles-Han S, Schneider R, Juvenile Idiopathic Arthritis Disease-Specific Research Committee of the Childhood A, et al. Adding canakinumab to the Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for systemic juvenile idiopathic arthritis: comment on the article by DeWitt et al. Arthritis Care Res (Hoboken). 2014;66(9):1430-1.
    • (2014) Arthritis Care Res (Hoboken) , vol.66 , Issue.9 , pp. 1430-1431
    • Kimura, Y.1    DeWitt, E.M.2    Beukelman, T.3    Stoll, M.L.4    Nigrovic, P.A.5    Onel, K.6    Prahalad, S.7    Angeles-Han, S.8    Schneider, R.9
  • 21
    • 80051741699 scopus 로고    scopus 로고
    • American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
    • Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Childhood Arthritis Rheumatology Research A, Pediatric Rheumatology Collaborative Study G, Paediatric Rheumatology International Trials O. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(7):929-36.
    • (2011) Arthritis Care Res (Hoboken) , vol.63 , Issue.7 , pp. 929-936
    • Wallace, C.A.1    Giannini, E.H.2    Huang, B.3    Itert, L.4    Ruperto, N.5
  • 22
    • 7544222361 scopus 로고    scopus 로고
    • Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis
    • Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology International Trials Organization: Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290-4.
    • (2004) J Rheumatol , vol.31 , pp. 2290-2294
    • Wallace, C.A.1    Ruperto, N.2    Giannini, E.3
  • 23
    • 84901606673 scopus 로고    scopus 로고
    • Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?
    • Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheum. 2014;66(6):1405-13.
    • (2014) Arthritis Rheum , vol.66 , Issue.6 , pp. 1405-1413
    • Nigrovic, P.A.1
  • 24
    • 39549087921 scopus 로고    scopus 로고
    • Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR)
    • Behrens EM, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T, Ayala R, Groh B, Finkel TH, Cron RQ. Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2008;35(2):343-8.
    • (2008) J Rheumatol , vol.35 , Issue.2 , pp. 343-348
    • Behrens, E.M.1    Beukelman, T.2    Gallo, L.3    Spangler, J.4    Rosenkranz, M.5    Arkachaisri, T.6    Ayala, R.7    Groh, B.8    Finkel, T.H.9    Cron, R.Q.10
  • 26
    • 79953324129 scopus 로고    scopus 로고
    • Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population
    • Jiang L, Wang Z, Dai X, Jin X. Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population. J Rheumatol. 2011;38(4):741-6.
    • (2011) J Rheumatol , vol.38 , Issue.4 , pp. 741-746
    • Jiang, L.1    Wang, Z.2    Dai, X.3    Jin, X.4
  • 27
    • 33847314256 scopus 로고    scopus 로고
    • Bayesian analysis of paired survival data using a bivariate exponential distribution
    • Lee J, Kim J, Jung SH. Bayesian analysis of paired survival data using a bivariate exponential distribution. Lifetime Data Anal. 2007;13(1):119-37.
    • (2007) Lifetime Data Anal , vol.13 , Issue.1 , pp. 119-137
    • Lee, J.1    Kim, J.2    Jung, S.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.